Isopropylphenidate

From Wikipedia, the free encyclopedia

Jump to: navigation, search
Isopropylphenidate
Isopropylphenidate structure.png
Systematic (IUPAC) name
propan-2-yl 2-phenyl-2-(piperidin-2-yl)acetate
Clinical data
Identifiers
93148-46-0 N
PubChem CID 68314762
Chemical data
Formula C16H23NO2
261.358

Isopropylphenidate (also known as IPH and IPPD) is a piperidine based stimulant drug, closely related to methylphenidate, but with the methyl ester replaced by an isopropyl ester. It has similar effects to methylphenidate but with a longer duration of action,[1][2] and was banned in the UK as a Temporary Class Drug from April 2015 following its unapproved sale as a designer drug.[3]

See also[edit]

References[edit]

  1. ^ Markowitz JS, Zhu HJ, Patrick KS. Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability. Journal of Child and Adolescent Psychopharmacology. 2013 Dec;23(10):648-54. doi: 10.1089/cap.2013.0074. PMID 24261661
  2. ^ John S. Markowitz, Kennerly S. Patrick, Haojie Zhu (Sep 27, 2012). "Patent US20120245201 - Isopropylphenidate for Treatment of Attention-Deficit/Hyperactivity Disorder and Fatigue-Related Disorders and Conditions". Retrieved 15 August 2014. 
  3. ^ Methylphenidate-based NPS: A review of the evidence of use and harm. Advisory Council on the Misuse of Drugs, 31 March 2015